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RESEARCH ARTICLE Open Access
Characterization of adipose-derived stromal/stem
cells from the twitcher mouse model of krabbe
disease
Xiujuan Zhang1, Julie A Semon1, Shijia Zhang1,2, Amy L Strong1, Brittni A Scruggs1,2, Jeffrey M Gimble3
and Bruce A Bunnell1,2,4*
Abstract
Background: Krabbe disease, also known as globoid cell leukodystrophy, is an autosomal recessive
neurodegenerative disease caused by the genetic deficiency of galactocerebrosidase (GALC), a lysosomal enzyme
responsible for the degradation of several glycosphingolipids like psychosine and galactosylceramide. In order to
investigate whether GALC deficiency in Krabbe disease affects adipose-derived stromal/stem cell (ASC) properties
and if the ASCs could be used as a source of autologous stem cell therapy for patients with Krabbe disease, ASCs
isolated from subcutaneous adipose tissue of Twitcher mice (a murine model of Krabbe disease) and their normal
wild type littermates were cultured, expanded, and characterized for their cell morphology, surface antigen
expression, osteogenic and adipogenic differentiation, colony forming units, growth kinetics, and immune
regulatory capacities in vitro.
Results: ASCs from Twitcher mice (TwiASCs), when compared to ASCs from normal mice (WtASCs), have a reduced
osteogenic differentiation potential, have less self-replicating and proliferative capacity, although they have the same
fibroblast morphologies and cell sizes. However, surprisingly, the TwiASCs demonstrated similar immune-suppressive
capacities as their counterparts WtASCs did when they were transwell co-cultured with macrophages in vitro.
Conclusion: This study reveals that Twitcher ASCs exhibit differences in the biologic potential when compared to their
counterparts from normal mice. The changes in Twitcher ASCs may be influenced by the GALC deficiency in Twitcher
mice. Nevertheless, none of the changes preclude the use of the TwiASCs for autologous applications.
Keywords: Adipose stem cells, ASCs, Krabbe disease, Twitcher mice, Autologous transplantation
Background
Krabbe disease, also known as globoid cell leukodystrophy,
is an autosomal recessive neurodegenerative lysosomal
storage disorder affecting both the central nervous sys-
tem (CNS) and peripheral nervous system (PNS) [1].
The disease is caused by the genetic deficiency of
galactocerebrosidase (GALC), a lysosomal enzyme respon-
sible for the degradation of several glycosphingolipids like
psychosine and galactosylceramide [1-4]. The accumula-
tion of GALC substrates, especially psychosine, leads to
progressive demyelination of axons and death of oligoden-
drocytes in the CNS and Schwann cells in the PNS [5].
Based on the age of onset and severity, Krabbe disease is
clinically divided into infantile type, juvenile type and adult
type [6]. The infantile Krabbe disease is most common
with onset between 3–6 months of age of symptoms in-
cluding vomiting, difficulty in feeding, extreme irritability,
complete blindness, deafness, spastic paralysis, extreme
emaciation and dementia, leading to death by 2 years of
age [6-10]. Currently, there is no cure for Krabbe disease.
The only approved clinical therapies for Krabbe disease
are bone marrow transplantation (BMT) and umbilical
cord blood transplantation (UCB), after myeloablative
chemotherapy, and such a procedure has only been bene-
ficial in the infantile type if it was performed before the
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onset of clinical symptoms [7,11]. However, the majority
of pre-symptomatic infants receiving transplantation have
been reported to develop severe disabilities, including
motor and language deterioration [11-13]. Moreover,
BMT and UCB therapies are limited by the scarcity of do-
nors, and can be complicated by the development of graft
versus host disease (GVHD), a serious and often fatal con-
dition resulting from the immunological attack of foreign
T cells against the patient [14]. One study had reported
that GVHD developed in 8 out of 11 asymptomatic and 5
out of 14 symptomatic Krabbe disease patients treated
with UCB [11].
Adipose-derived stromal/stem cells (ASCs) can be iso-
lated from lipoaspirate following liposuction. ASCs have
the potential to differentiate into adipocytes, osteocytes,
chondrocytes, myocytes and neuronal cells when stimu-
lated with appropriate induction factors [15-21]. ASCs
have received increasing attention from both biological sci-
entists and clinicians because of the cells’ ability to differ-
entiate into multiple lineages, the abundance and easy
accessibility of adipose tissues, and the feasibility of harvest
by a minimally invasive procedure. In addition, ASCs have
been reported to reduce inflammation [22,23] and secrete
growth, angiogenic and anti-apoptotic factors [24,25].
Therefore, ASCs from individual Krabbe disease patients
may be a source of mesenchymal stromal/stem cells for au-
tologous cell therapy. Autologous transplantation has
lower rates of post-transplant complications and infections
compared to allogeneic transplantation. Moreover, there
are no concerns about donor availability and risk of
histoincompatibility in autologous transplantation. Autolo-
gous ASCs offer numerous advantages from regulatory,
histocompatibility, and immunological perspectives [26].
The Twitcher mouse model was developed through
spontaneous mutation of the GALC gene at the Jackson
Laboratory in 1976 [8,27,28] and shares many neuro-
pathologic findings with the human infantile type of
Krabbe disease. In this study, ASCs harvested from
Twitcher mice (TwiASCs) and normal wild type mice
(WtASCs) from the same litters were culture expanded,
characterized, and compared based on features such as
differentiation potential, colony forming unit capabilities,
cell surface marker profiles, growth kinetics and cytokine
expression.
Results
Morphology and cell size of TwiASCs and WtASCs
The cell morphology of TwiASCs was consistent with
that of the WtASCs, which were fibroblast-like in ap-
pearance (Figure 1A). The sizes of both cell types were
also analyzed based on the forward scatter signals of
flow cytometry. As shown in Figure 1B, the cell size of
TwiASCs versus WtASCs was not significantly different
(t-test, P>0.05).
Flow cytometric analysis of surface antigens on TwiASCs
and WtASCs
ASCs from Twitcher mice and normal wild type mice
were isolated, cultured, expanded, and analyzed for surface
markers by flow cytometry at passage 3. ASC surface
markers CD29, Sca1, and CD106; hematopoietic mark-
ers CD34 and CD45; phagocytic lineage marker CD11b;
and endothelial marker CD31 were tested. As shown in
Figure 2, both TwiASCs and WtASCs were positive for
CD29, Sca1, and CD106. Both cell types are negative for
CD45, CD11b, and CD31. However, there is a significant
difference in CD34 expression between TwiASCs and
WtASCs (t-test, P<0.05). The ASCs were harvested from
three Twitcher mice and three wild type mice respectively,
and both TwiASCs and WtASCs were repeated three
times independently by flow cytometry and similar results
were obtained in all studies.
Differentiation assays for TwiASCs and WtASCs
Twitcher ASCs and wild type ASCs were cultured in
osteogenic and adipogenic differentiation medium for
3 weeks to test their lineage differentiation efficiency.
On day 21, the ASCs were stained with Alizarin Red to
assess bone mineralization, and with fresh Oil Red O for
lipid droplets. Both TwiASCs and WtASCs efficiently
differentiated into osteocytes and adipocytes (Figure 3).
However, as shown in Figure 3A, the WtASCs appear to
have greater differentiation capacity for osteogenic dif-
ferentiation than the TwiASCs. Quantification of the dif-
ferentiation levels of both cell types (Figure 3B) further
demonstrated that WtASCs (OD ratio=11.39±0.73)
could differentiate into osteocytes to a much greater
degree than TwiASCs (OD ratio=5.78±0.17) (t-test,
P<0.05) over the period of the assay. Quantification of
adipocyte differentiation indicated that WtASCs (OD ra-
tio=1.20±0.07) have a slightly higher capacity than
TwiASCs (OD ratio=1.01±0.10), but not statistically sig-
nificant (t-test, P>0.05). The graph in Figure 3B repre-
sents the ratios of OD of differentiated cells normalized
to control cells.
Osteogenic markers in WtASC and TwiASC
As shown in Figure 3, WtASCs appear to have greater dif-
ferentiation capacity for osteogenic differentiation than
the TwiASCs. To further investigate their osteogenic po-
tentials, replicate cultures of WtASC and TwiASC were
induced to undergo osteogenic differentiation and
harvested on day 7, 14 and 21 for alkaline phosphatase
(ALP), runt-related transcription factor 2 (RUNX), and
osteocalcin (OCN) mRNA analysis by real-time PCR. ALP
catalyzes the hydrolysis of monophosphate esters at a high
pH, and it is one of the first functional genes expressed in
the process of calcification [29]. RUNX is a bone-specific
transcription factor, and it stimulates OCN and other bone
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specific gene transcriptions via the binding of its runt do-
main to their promoters [30]. OCN, a marker of bone for-
mation, is the most abundant and most widely studied
non-collagenous protein in bone [31]. As demonstrated in
Figure 4, WtASCs have a much higher ALP mRNA ex-
pression than TwiASC on day 7 (t-test, P<0.05). By day 21,
WtASCs demonstrated higher expression in all the three
lineage markers than TwiASC (t-test, P<0.05) (Figure 4).
Colony forming unit assay
The colony forming unit (CFU) assay was used to assess
the self-renewal ability of the cells. Both TwiASCs and
WtASCs were seeded onto 56.7 cm2 Nunc cell culture
plates at a total of 100 cells per plate and the number of
colonies was enumerated after 14 days of culture. The CFU
assay results (Figure 5) demonstrated that WtASCs have a
significantly higher self-replicating capacity (6.20±1.62)
than TwiASCs (1.60±0.51) (t-test, P<0.05).
Growth kinetics of TwiASCs and WtASCs
In order to test their proliferative capacity, TwiASCs and
WtASCs were plated on 56.7 cm2 Nunc cell culture plates
at a density of 500 cells/cm2 and cultured for 10 days. The
fold-increase in cell number was analyzed every 2 days
throughout the culture period and was calculated by com-
paring the cell number at each time point to the original
plating numbers. As illustrated in Figure 6, the TwiASCs
have a much slower growth rate than WtASCs. For the
10-day culture period, TwiASCs only had a maximal fold-
increase highest of 5.49 ±1.29 while WtASCs had a max-
imum of 12.10 ±0.38. After that, both TwiASCs and
WtASCs reached their growth plateau and started to
decline.
Regulation of TwiASCs and WtASCs on inflammatory
cytokine expression in primary macrophages
The thioglycolate-elicited peritoneal primary macro-
phages were seeded onto 24-well cell culture plates. After
6-hour incubation, 0.4 μm pore size transwells were
placed in the 24 well plates and TwiASCs and WtASCs
were added on top of each transwell. The transwell co-
culture was incubated overnight followed by stimulation
of the cells with LPS for an additional 24 hours. The ex-
pression levels of inflammatory cytokines, IL-1α, IL-1β,
TNFα, IL-6 and IL-10 were analyzed by real-time
PCR to determine whether TwiASCs and WtASCs could
A) TwiASC WtASC
B)
Figure 1 Morphology and cell size of TwiASCs and WtASCs. A) Morphology of TwiASCs and WtASCs. Both cell types retain the thin spindle
fibroblast-like morphology described for ASCs. B) Cell size based on forward scatter signal of flow cytometry (P=0.96, t-test, n≥10).
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effectively regulate their expression. As illustrated in
Figure 7, little cytokine production was observed in
macrophages in the absence of LPS, and LPS stimula-
tion triggered an outburst of cytokine production by
macrophages, especially the pro-inflammatory IL-1α,
IL-1β, TNFα, IL-6 cytokines. Remarkably, WtASC sig-
nificantly reduced the macrophage ability to produce
IL-1α (t-test, P<0.01), IL-1β (t-test, P<0.01), TNFα
(t-test, P<0.01), IL-6 (t-test, P<0.05), and enhanced
the production of the anti-inflammatory cytokine IL-10
(t-test, P<0.05). TwiASCs demonstrated similar immune-
suppressive capacities in vitro as WtASCs with the excep-
tion that they did not suppress the IL-6 expression by the
macrophages (Figure 7, t-test, P>0.05).
Discussion
This study compared adipose stem cells from Twitcher
mice to those isolated from their wild type littermates in
order to determine whether ASCs with the mutation as-
sociated with Krabbe disease continue to display normal
phenotype. This has relevance to their potential use in
future transplantation studies.
From the morphologic perspective, TwiASCs and
WtASCs appeared similar with a fibroblast-like morphology
and had no significant difference in cell size based on direct
observation and on the forward scatter data of flow
cyotmetry. Both TwiASCs and WtASCs were analyzed by
flow cytometry for specific cell surface markers such as
CD29, CD106, Sca1, CD45, CD34, CD11b, and CD31. The
cell surface marker profiles for both cell types were com-
parable with the exception of CD34 expression where
there was a significant difference between TwiASCs and
WtASCs. The expression of CD34 differed as a function
of passage numbers for TwiASCs. It was positive in pas-
sage 3 as shown in Figure 2, but gradually diminished its
expression along higher passages, which is typical of
ASCs in culture (data not shown). There have been re-
ports showing that CD34 is consistently down- regulated
while culturing over several passages [24,32], which is
consistent with our findings that TwiASCs gradually
lost their expression of CD34 over progressive pas-
sages while all other surface markers tested remained
the same. However, there have been never detectable
levels of CD34 expression in WtASCs. CD34 is a sur-
face marker for hematopoietic stem cells, endothelial
B)
A)
Figure 2 Cell surface phenotype analysis of TwiASCs and WtASCs. A) Cells were analyzed by flow cytometry for MSC surface markers CD29,
Sca1 and CD106; hematopoietic markers CD34 and CD45; phagocytic lineage marker CD11b; and endothelial marker CD31. Gray filled: isotype
control; gray line: WtASCs; black line: TwiASCs. B) The percentage expression of each surface marker. All cells were analyzed at passage 3.
# means P< 0.05 vs TwiASCs for CD34 (t-test, n=3).
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progenitor cells and satellite cells. The difference of
CD34 expression between TwiASCs and WtASCs may
be due to differences between the adipocyte niches
within adipose depots of Twitcher mice and their wild
type littermates.
Both TwiASCs and WtASCs could be readily differen-
tiated into osteocytes and adipocytes. Although the lipid
droplets produced by WtASCs were larger, in general,
than those of TwiASCs as observed under the micro-
scope, there was no significant difference in the accumu-
lation of neutral lipids between TwiASCs and WtASC.
However, WtASCs exhibited an increased differentiation
along the osteogenic lineage relative to TwiASCs. The
study of osteogenic markers in differentiated WtASC
and TwiASC (Figure 4) demonstrated that WtASCs,
compared to TwiASCs, have significantly increased levels
of expression. ALP is a cell surface glycoprotein that is in-
volved with mineralization and its role in mineralization
process occurs during early differentiation. Measurement
of increased ALP expression at the mRNA level has been
taken as a reliable indication of the osteoblastic phenotype
[29,33]. OCN is a matrix protein that regulates osteoclast
activity, and is a late marker of differentiation at the
mineralization stage [33]. Reduced osteogenic differenti-
ation capacity of TwiASCs correlated with reduced ALP
and OCN expression of TwiASCs, although the mechan-
ism(s) regulating the reduced ALP and OCN expression in
TwiASCs is unclear. However, it has been noticed that
Twitcher mice demonstrated postnatal bone retardation,
and Contreras and colleagues [34] demonstrated that






Figure 3 Qualitative and quantitative differentiation of TwiASCs and WtASCs along osteogenic and adipogenic lineages. A) Image of
differentiated TwiASCs and WtASCs. Passage 3 TwiASCs and WtASCs were incubated in adipogenic or osteogenic differentiation media for
21 days and stained, respectively, with Oil Red O and Alizarin Red. For osteogenic differentiation, images were collected at 4× magnification. For
adipogenic differentiation, images were obtained at 10× magnification. B) Quantification of osteogenesis and adipogenesis. For the quantitation
of osteogenesis, the cells were de-stained with 10% cetylpyridinium chloride after stained with Alizarin Red. For the quantitation of adipogenesis,
the cells were de-stained with isopropanol. Optical density (OD) was measured at 584 nm and normalized to protein content. The bar graph
represents the ratio of normalized OD of differentiated cells and normalized OD of control cells. # means P< 0.05 vs WtASCs (t-test, n=3).
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Twitcher mice demonstrated osteopenic phenotype, and
their bones were much smaller and weighed less compared
to normal mice. The same group [34] also reported that
the accumulated psychosine induced by GALC-deficiency
is one of the potential factors that resulted in the stunted
bone growth in Twitcher mice. Psychosine accumulation
in TwiASCs may play a role in their reduced differentiation
capacity along the osteogenic lineage.
The colony forming unit assay and growth curve ana-
lyses were used to compare the self-renewal and prolifer-
ative capacities between the TwiASCs and WtASCs. The
results clearly indicated that the TwiASCs have a signifi-
cantly reduced ability to form single-cell-derived colonies
when plated at low density in comparison with the
WtASCs. Moreover, cultures of TwiASCs seemed to
grow much slower than did their wild type counterparts.
However, many studies have demonstrated that the
therapeutic effects of ASCs are not only solely the results
of their capacity for differentiation along mesenchymal
and non-mesenchymal lineages, but more importantly
related to their immune regulatory capacities [23,35-38].
Macrophages are a key component of the innate immune
system and are widely distributed in many different tis-
sues. In addition to their role in initial phases of immune
defense, macrophages play an indispensable role in later
phases of tissue homeostasis and repair. The interaction
of mesenchymal stem cells (MSCs) with macrophages
has been widely investigated in recent years [39-42].
Ne’meth et al. [40] demonstrated that MSCs increased
the IL-10 production by LPS-stimulated macrophages
in vitro. They also demonstrated that administration of
# **
*
Figure 4 Real-time PCR analysis of osteogenic lineage marker expression in differentiated TwiASCs and WtASCs. TwiASCs and WtASCs were
induced for osteogenic differentiation. On day 7, 14 and 21, the cells were harvested and total RNA was extracted for PCR analysis of osteogenic markers
ALP, RUNX and OCN. # means P< 0.05 vs WtASCs on day 7 and * means P< 0.05 vs WtASCs on day 21 for ALP, RUNX and OCN respectively (t-test, n=6).
#
Figure 5 Colony forming unit assays for TwiASCs and WtASCs.
100 cells were plated on 56.7 cm2 Nunc cell culture plates and
incubated for 14 days. Cells were stained with 3% crystal violet, and
colonies 2 mm or larger in diameter were counted. # means P< 0.05
vs WtASCs (t-test, n=5).
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MSCs improved organ function and reduced mice mor-
tality for the treatment of sepsis, and the therapeutic
effects of MSCs were induced upon their stimulation by
IL-10 produced by macrophages. In our study, the
TwiASCs and WtASCs were co-cultured in transwell
plates with peritoneal macrophages stimulated by LPS,
and the in vitro expression of inflammatory cytokines by
macrophages was analyzed by real-time PCR. The results
indicated that TwiASCs demonstrated similar immune-
suppressive capacities in vitro as their counterparts
WtASCs. These data suggested that, although TwiASCs
had reduced osteogenic differentiation, self-renewal and
proliferative capacities, they are quite similar to WtASCs
in their anti-inflammatory properties. This is an import-
ant finding since the therapeutic effects of adult stem cell
therapy had been shown more related to their immune-
modulatory capacities.
Conclusion
ASCs from Twitcher mice, when compared to ASCs
from normal mice, have a reduced osteogenic differenti-
ation potential, have less self-replicating and proliferative
capacity, although they have the same fibroblast morph-
ology and cell sizes. However, surprisingly, the TwiASCs
demonstrated similar immune-suppressive capacities as
their counterparts WtASCs did when they were co-
cultured with macrophages in vitro. These findings suggest
that while the GALC deficiency in Twitcher mice does in-
fluence ASC profiles in some aspects, it does not affect
their immune-suppressive capacities significantly. These
outcomes have relevance since the immune-suppressive
function is potentially a critical mechanism that would
account for the therapeutic benefit of ASC transplantation
in Krabbe disease.
Methods
Isolation and culture of adipose-derived stem cells
The Twitcher mice and their littermates were obtained
from breeding pairs carrying a natural mutation in the
GALC gene. Breeding pairs were originally purchased
from the Jackson Laboratory (Bar Harbor, ME). All the
protocols and experimental procedures were approved
by the Institutional Animal Care and Use Committee at
Tulane University. Genotyping of Twitcher mice was
performed on post-natal day 14 by real time PCR modi-
fied as previous described [43]. The subcutaneous fat
pads were isolated from the post-natal day 34 moribund
Twitcher mice and their wild type littermates, rinsed with
Hank’s balanced salt solution (HBSS) (Life Technologies,
Grand Island, NY) to remove blood and hair contamin-
ation, and digested with 0.1% collagenase type 1 solution
(Life Technologies) for approximately 4 hours at 37°C
under vigorous agitation. The digested adipose tissue sam-
ples were then filtered through a 70-μm nylon mesh cell
strainer (BD Biosciences, Bedford, MA), and centrifuged at
500×g for 10 minutes at room temperature (RT). The pel-
lets were re-suspended and cultured in the growth medium




Figure 6 Growth curve analysis of TwiASCs and WtASCs. The cells were originally seeded at 500 cells/cm2 in 56.7 cm2 Nunc cell culture
plates and cultured for 10 days. Fold increase in cell number was analyzed every 2 days throughout the culture period and was calculated by
comparing the cell number at each time point to the original plating cell number. # means P< 0.05 vs WtASCs on day 6 and day 10 respectively,
and ## means P< 0.001 vs WtASCs on day 8 (t-test, n=3).
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fetal bovine serum (FBS) (Atlanta Biologicals, Atlanta,




The following antibodies were used to define the surface
markers expressed by the ASCs: CD29-FITC (fluorescein
isothiocyanate), CD34-FITC, CD106-PE (vascular cell
adhesion molecule-1 (VCAM-1)), CD31-PE (phycoeryth-
rin), CD45-PE, CD11-PE, and Sca1-PE (stem cell
antigen-1). All of the antibodies were purchased from
BD Biosciences. The ASCs were cultured to 70% conflu-
ence, trypsinized, pelleted, and re-suspended in 500 μl
phosphate buffered saline (PBS) (Life Technologies). The
cells were incubated with the antibodies for 30 minutes
at RT, then washed with PBS, and analyzed by Cytomics
FC500 (Beckman Coulter, Brea, CA). The results were
analyzed with CXP analysis software (Beckman Coulter).
Colony forming unit assay
ASCs at passage 3 were seeded onto 56.7 cm2 Nunc cell
culture plates (Nalge Nunc International, Rochester, NY)
in 5 replicates at a total of 100 cells per plate. Growth
media was changed every 3–4 days. After 14 days, the
cells were washed with PBS, stained with 3% crystal vio-
let in 100% methanol for 30 minutes at RT, and then
washed with deionized (DI) water at least 3 times to re-
move excess dye. All colonies greater than 2 mm in
diameter were counted.
## 








Figure 7 The inflammatory cytokine profiles of LPS-stimulated macrophages. The ASCs and thioglycolate-elicited macrophages were
transwell co-cultured and incubated for another 24 hours in the presence of 30 ng/ml LPS. The macrophage cells were collected, and total RNA
was extracted for real-time PCR quantification of inflammatory cytokines IL-1α, IL-1β, TNFα, IL-6 and IL-10. The macrophage (MФ) alone and LPS
stimulated macrophage (MФ+LPS) were used as controls. ## means P< 0.01 MФ+LPS vs MФ+LPS (WtASCs) (t-test, n=3); **means P< 0.01
MФ+LPS vs MФ+LPS (TwiASCs) (t-test, n=3); # means P< 0.05 MФ+LPS vs MФ+LPS (WtASCs) (t-test, n=3); and ¥ means P< 0.05 MФ+LPS(WtASCs)
vs MФ+LPS (TwiASCs) (t-test, n=3).
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Differentiation
ASCs at passage 3 were seeded with a density of 6×104
cells/well on 6-well Nunc plates (Nalge Nunc Inter-
national) and cultured to approximately 90% confluence
before adipogenic and osteogenic differentiation media
were added. Adipogenic differentiation medium was
ASC growth medium supplemented with 5 μg/ml insu-
lin, 50 μM indomethacin, 1 μM dexamethasone and
0.5 μM 3-isobutyl-1-methylxanthine (all media supple-
ments were purchased from Sigma, St Louis, MO).
Osteogenic differentiation medium was ASC growth
medium supplemented with 1nM dexamethasone, 20 mM
β-glycerolphosphate, 50 μM L-ascorbic acid 2-phosphate
sesquimagnesium salt, and 50 ng/ml L-thyroxine sodium
pentahydrate. Media were changed twice per week for
3 weeks. For adipogenic differentiation, the cells were
washed with PBS, fixed with 10% formalin (Sigma) for
20 minutes at RT, washed again with PBS, stained with
Oil Red-O (Sigma) for 20 minutes at RT, washed again
with PBS until wash was clear. For the detection of osteo-
genesis, the cells were washed with PBS, fixed with 10%
formalin for 20 minutes at RT, washed again with DI
water, stained with Alizarin Red (Sigma) for 20 minutes at
RT, washed again with DI water until wash was clear. Im-
ages were acquired at 10× for adipogenic differentiation
and 4× for osteogenic differentiation on Nikon Eclipse
TE200 (Melville, NY) with Nikon Digital Camera
DXM1200F using the Nikon ACT-1 software version 2.7.
The *levels of adipogenic and osteogenic differentiation
were also quantitated. For the quantitation of adipogenic dif-
ferentiation, the accumulated lipids were eluted with isopro-
panol after images were captured. The amount of Oil Red O
was measured by recording the optical density (OD) of the
solution at 584 nm. The results were normalized to the pro-
tein content of the samples with the BCA assay (Thermo
Scientific, Rockford, IL). For the quantitative osteogenesis
assay, the cells were de-stained, after images were taken,
with 10% cetylpyridinium chloride (Sigma) for 30 minutes at
RT. The amount of Alizarin Red was determined by meas-
uring the OD of the solution at 584 nm. The results were
normalized to the protein content of the samples.
Real-time PCR analysis of osteogenic markers in WtASC
and TwiASC
Total RNA was extracted from differentiated WtASC
and TwiASC on day 7, day 14, and day 21 using RNeasy
Mini Kit (Qiagen, Valencia, CA). RNA concentration
and purity were assessed by Nanodrop 2000C spectropho-
tometer (Thermo Scientific). First strand cDNA syntheses
were performed using iScript cDNA Synthesis kit (Biorad,
Hercules, CA) after RNA was first treated with DNase (Life
Technologies). Primers for mouse alkaline phosphatase
(ALP), Runx-2 (RUNX), and osteocalcin (OCN) were com-
mercially synthesized (IDTDNA, Coralville, Iowa), and the
sequence of the primers was as previously described [44].
The housekeeping gene β-actin (UniGene: Mm328431)
was used as internal reference. The PCR reactions were
performed using CFX96 Real Time System (Biorad) in a
total final volume of 25 μl containing 12.5 μl SYBR green
supermix (Biorad), 1 μl forward primer and 1 μl reverse
primer (400 nM), and 1 μl template (500 ng). Reaction
mixtures were incubated at 95°C for 3 minutes, and reac-
tions were allowed to proceed via 45 cycles of melting at
95°C for 15 seconds, annealing and extension at 57°C for
30 seconds. Quantification was calculated using ΔΔCt
method [44].
Growth curve
ASCs at passage 3 were seeded onto 56.7 cm2 Nunc cell
culture plates in triplicate with a seeding density of 500
cells/cm2. Growth medium was changed every 3–4 days.
Every 2 days for a total of 10 days, the cells were
trypsinized, pelleted, re-suspended in 500 μl PBS, and
counted using a CountessW Automated Cell Counter (Life
Technologies) to analyze the fold increase in cell number.
Macrophage and ASCs co-culture
Primary macrophages were obtained through thioglycolate-
elicited peritoneal isolation using a slightly modified pub-
lished method [42]. Briefly, 1 ml 3% (w/v) sterile thioglycolate
(Sigma) in DI water was injected intraperitoneally into
C57Bl6 mice (Jackson Lab) to elicit peritoneal exudate
cells. Four days after thioglycolate injection, cells were
harvested by peritoneal lavage using 10 ml PBS, treated
with red blood cell lysing buffer (Sigma) to remove the
red blood cells, assessed for macrophage purity by flow cy-
tometry using FITC-labeled IgG anti-CD11b (BD Biosci-
ences), and finally plated onto 24-well Nunc cell culture
plates (Nalge Nunc International) with 200,000 cells per
well in RPMI medium (Life Technologies) supplemented
with 10% heat inactivated FBS and 1% penicillin/strepto-
mycin. After 6-hour incubation, the non-adherent cells
were removed by vigorous washing with PBS. Then
0.4 μm pore size 24 well transwell inserts (Corning, Lowell,
MA) were placed into the 24-well plate, and TwiASCs or
WtASCs were plated in each transwell insert with 40,000
cells per well (ASC: macrophage ratio=1:5). Cells were cul-
tured overnight, incubated another 24 hour after the
addition of 30 ng/ml lipopolysaccharide (LPS, Sigma), and
then total RNA was extracted from the macrophages using
RNeasy Mini Kit. RNA concentration and purity were
assessed by Nanodrop 2000C spectrophotometer.
Real-time quantitative PCR
RNA was first treated with DNase, and first strand
cDNA syntheses were performed using iScript cDNA
Synthesis kit. Real-time PCR assay was performed to
analyze the levels of mouse inflammatory cytokines IL-1α,
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IL-1β, TNFα, IL-6 and IL-10 expressed by macrophages
transwell co-cultured with TwiASCs and WtASCs. PCR
analyses were performed using CFX96 Real Time System
in a total volume of 20 μl containing 10 μl Taqman
mastermix (Applied Biosystems, Foster City, CA), 1 μl pri-
mer and probe mix (Applied Biosystems), and 2 μl tem-
plate. Reaction mixtures were incubated at 50°C for
2 minutes and 95°C for 10 minutes, and reactions were
allowed to proceed via 40 cycles of melting at 95°C for
15 seconds, annealing and extension at 60°C for 1 minute.
The housekeeping gene β-actin (UniGene: Mm328431)
was used as internal reference. Quantification was calcu-
lated using ΔΔCt method [45]. Controls were RNA from
macrophages cultured alone with and without LPS.
Statistical analysis
Groups of data were analyzed by one-way analysis of
variance (ANOVA). For pair-wise comparisons, the
F-test was used to determine whether a given pair of
population variances was equal (α<0.05). This informa-
tion was then used in designating the appropriate t-tests
(typically heteroscedastic) to perform for comparing the
means of population pair, with significance defined as
P<0.05. All values were reported as mean± SD.
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